Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis

ClinicalTrials.gov ID: NCT05019742

Public ClinicalTrials.gov record NCT05019742. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 4:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled Trial to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

SPH3127-US-01 is a multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety, pharmacokinetics, and preliminary efficacy of SPH3127 for the treatment of mild-to-moderate ulcerative colitis.

Study identification

NCT ID
NCT05019742
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Enrollment
3 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 21, 2022 (Actual)
Primary completion
Nov 1, 2022 (Actual)
Completion
Nov 1, 2022 (Actual)
Last update posted
Jun 26, 2025

2022

United States locations

U.S. sites
16
U.S. states
8
U.S. cities
16
Facility City State ZIP Site status
Clinical Research Associates, LLC Huntsville Alabama 35801 —
Southern California Research Institute Medical Group, Inc. Los Angeles California 90045 —
Facey Medical Group at Facey Medical Foundation Mission Hills California 91345 —
Precision Research Institute San Diego California 92114 —
Ventura Clinical Trials Ventura California 93003 —
Clinical Research of West Florida Clearwater Florida 33765 —
Velocity Clinical Research Edgewater Florida 32132 —
Homestead Research Institute, Inc. Homestead Florida 33030 —
IHS Health Kissimmee Florida 34741 —
Bayside Clinical Research LLC Trinity Florida 34655 —
Atlanta Center for Gastroenterology, P.C. Decatur Georgia 30033 —
Gastroenterology Associates of Western Michigan, PLC Wyoming Michigan 49519 —
NY Scientific Brooklyn New York 11235 —
Southern Star Research Institute, LLC San Antonio Texas 78229 —
Gastro Health & Nutrition - Victoria Victoria Texas 77904 —
Velocity Clinical Research Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05019742, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2025 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05019742 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →